We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JWEL:NASDAQJowell Global Ltd. Analysis

Data as of 2026-05-19 - not real-time

$2.28

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: JWEL is trading at $2.28, well below its 20‑day and 50‑day SMAs (~$2.45) and just above the identified support of $2.20. The MACD is in a bearish configuration and the RSI sits around 41, indicating limited upside momentum. Volume is rising but 30‑day volatility is extremely high at roughly 48%, suggesting price swings could be pronounced. Fundamental outlook: The company reports negative earnings, a gross margin of just 5% and operating losses, with revenue declining 11% year‑over‑year. Yet the price‑to‑book ratio is a mere 0.32 and a discounted cash‑flow model implies a fair value near $21, highlighting a stark valuation gap. The balance sheet shows modest debt (Debt‑to‑Equity >11) but cash is limited, and there is no dividend. Risk profile: Low beta (0.45) tempers market‑wide moves, but the stock’s micro‑cap size, high volatility, and exposure to China’s consumer‑cyclical internet retail sector introduce significant liquidity, regulatory, and geographic risks.
Overall, while the market pricing appears dramatically cheap relative to intrinsic estimates, the company’s weak profitability, declining sales, and sector‑specific headwinds make any upside highly speculative. Investors should weigh the deep discount against the substantial operational and macro‑environmental uncertainties before taking a position.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD and neutral‑to‑bearish RSI
  • Proximity to support with high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Large valuation gap versus DCF fair value
  • Continued negative earnings and cash flow
  • Uncertainty around turnaround or strategic restructuring

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential for deep value if restructuring succeeds
  • Persistent regulatory and geographic headwinds in China
  • Lack of dividend and low profitability limiting total return

Key Metrics & Analysis

Financial Health

Revenue Growth-11.10%
Profit Margin-4.45%
Debt/Equity11.76
P/B Ratio0.3
Op. Cash Flow$5.0M

Technical Analysis

TrendNeutral
RSI40.9
Support$2.20
Resistance$2.76
MA 20$2.45
MA 50$2.45
MA 200$2.14
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair Value$20.94
GradeUndervalued
TypeValue

Risk Assessment

Beta0.45
Volatility48.18%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.